Investor Alert - $GACR Green Automotive Co. In Up-Trend !!
Alert - $GACR Green Automotive Co. In Up-Trend !!
Ticker: GACR
GACR Good News !
http://www.businesswire.com/news/home/2014092...Facilities
Have a look also to GAC Newport !
http://www.newportcoachworks.com/
By Av. they going to produce about 234 Busses Annually !
Take the Av. Price of $ 150 K x 234 and it gets to $ 35,1 Mn
Annual Revenue and at 30 % Gross Profit it gets $ 10,53 Mn !
GACR In General !
http://www.investorshangout.com/post/view?id=1773448
For Happy Investing
.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...
Continue Reading
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue Reading
TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...
Continue Reading
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...
Continue Reading
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...
Continue Reading
Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....
Continue Reading
Top 5 Most Recently Viewed Articles
Itafos Strengthens Financial Position with Credit Facility Amendments Itafos Inc. (TSX-V: IFOS) has recently taken a significant step to enhance its financial flexibility and liquidity by amending its credit facilities. This development is vital for the company's ongoing projects, particularly the H1/NDR initiative, which aims to extend the operational life of the Conda...
Continue Reading
Understanding Renault S.A.’s Voting Rights and Share Capital Renault S.A., a notable player in the automotive industry, recently made significant disclosures regarding its voting rights and share capital. These updates are essential for shareholders, investors, and market analysts as they navigate financial decisions surrounding the company. Key Details Disclosed by...
Continue Reading
Embracing Innovation in Sports Betting In the rapidly changing world of sports betting, innovation is key. RealBookies.com has emerged as a trailblazer, offering cutting-edge sportsbook software solutions designed to cater to both aspiring entrepreneurs and seasoned operators. By leveraging advanced technology, they empower users to thrive in the global sports wagering...
Continue Reading
Immunovia AB (publ) saw a hefty spike in its registered shares recently, totaling 169,711,476 as of September 2024. This surge came on the heels of a rights issue resolved by the board—essentially a cash grab to shore up their footing in the cutthroat healthcare sector. Traders caught wind of these moves, but let's break down what's really brewing under the surface....
Continue Reading
Bloomberg Law Recognizes Innovative Law School Programs Bloomberg Law has recently unveiled the ten finalists for its esteemed Law School Innovation Program. This initiative, now running into its third year, is dedicated to identifying and honoring law schools that are at the forefront of educational innovation. The focus of this year's program is to enhance career...
Continue Reading